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regulation of blood pressure and vessel tone in the car-S-Nitrosylation of NSF
diovascular system (Foster et al., 2003). It is also knownControls Membrane Trafficking that impairments in NO-mediated regulation underlie
several pathophysiological conditions, such as diabe-
tes, chronic inflammation, atherosclerosis, and hyper-
tension. In many cases however, the molecular NO tar-
Nitric oxide is a diffusible molecule with profound ef- gets are unkown.
fects on regulated exocytosis in several biological In order to identify the molecular targets that may
systems—however, the molecular targets remain elu- account for the anti-inflammatory effect of NO in the vas-
sive. In this issue of Cell, Matsushita et al. report that cular system, Matsushita and colleagues (2003) studied
in aortic endothelial cells, S-nitrosylation of NSF, an regulated exocytosis in human aortic endothelial cells.
ATPase essential for the activation of the membrane- NSF was an obvious candidate for S-nitrosylation, be-
fusion machinery, inhibits the exocytosis of Weibel- cause it was originally identified as the N-ethylmalei-
Palade bodies, secretory granules containing a cock- mide-sensitive factor in membrane trafficking (N-ethyl-
tail of mediators essential to the regulation of vascular maleimide alkylates thiol groups such as cysteines)
vessel tone. (Block et al., 1988). Endothelial cells contain Weibel-
Palade bodies—secretory granules rich in von Wille-
brand factor (vWF) and P-selectin, both of which areRegulated exocytosis and the release of bioactive mole-
critical for platelet adhesion during the inflammatorycules are essential events in physiological processes
response to injury in blood vessels. At the cellular level,such as neurotransmission, the immune response to
the authors show that exogenous NO donors and endog-microbial infections, wound healing, and the control of
enous NO production by endothelial NO synthase (eNOS)the blood glucose level. Exocytosis involves the con-
reversibly inhibit stimulation-dependent exocytosis oftrolled fusion of mediator-containing storage granules
vWF. At the physiological level, they demonstrate thatwith the plasma membrane. The basic fusion process is
mice treated with NO inhibitors or lacking eNOS displaymediated by the assembly of v-SNAREs on the secretory
augmented platelet adherence to venule walls (an effectvesicle with their cognate t-SNAREs on the plasma
known as “platelet rolling”) and reduced bleeding times,membrane (So¨llner, 2003). Several additional regulatory
which correlate with increased exocytosis of Weibel-proteins control t-SNARE and v-/t-SNARE complex as-
Palade bodies. At the molecular level, the authors de-sembly, provide spatial and temporal control, and en-
termine that three out of nine cysteines in NSF are ni-sure that fusion is responsive to specific signals that
trosylated in vitro. Alanine scanning mutagenesis thentrigger exocytosis. Upon fusion, an extremely stable
revealed that two of the three cysteines (C91 and C264)four-helix v-/t-SNARE bundle resides in a single lipid
are required for NSF to disassemble v-/t-SNARE com-
bilayer, which must be disassembled to allow v- and
plexes, but are not necessary for the SNAP-dependent
t-SNARE recycling and additional rounds of transport.
interaction with SNARE complexes. In contrast to the
This process is catalyzed by ATP hydrolysis mediated alanine mutants, S-nitrosylation does not affect the
by the hexameric ATPase NSF. In addition to this primary basal ATPase activity. Importantly, S-nitrosylation of
regulation, transient reversible control mechanisms me- NSF is reversible in vitro and in vivo. Finally, the addition
diated by posttranslational protein modifications modu- of recombinant NSF but not S-nitrosylated NSF to NO-
late membrane trafficking dependent on internal or envi- pretreated, permeabilized endothelial cells restores
ronmental signal queues (e.g., up/down regulation of vWF release, clearly demonstrating that NSF-inactiva-
membrane fusion at distinct stages of the cell cycle and tion by NO is a major regulator of exocytosis. Interest-
potentiation/depression of neurotransmission in learn- ingly, the addition of recombinant NSF caused a relative
ing and memory). increase in exocytosis in NO-pretreated cells compared
The classic example of a posttranslational modifica- to untreated cells, indicating that NO targets additional
tion is protein phosphorylation that controls cellular and components that stimulate exocytosis.
intercellular communication. Thus, not surprisingly, the The findings by Matsushida et al. powerfully establish
activation/deactivation of specific kinases and phos- a causal link between an NO-controlled physiological
phatases also fine-tunes membrane trafficking (Turner process and its cellular and molecular mechanisms. To-
et al., 1999). However, the discovery of the gaseous gether, the data imply that NSF nitrosylation is a general
modulator nitric oxide (NO) and NO synthases (NOS) has strategy to regulate exocytosis independently of the ini-
revealed an independent, chemically and functionally tial stimulus and signal transduction pathway triggering
distinct regulatory system, which modifies different sites membrane fusion. Furthermore, they suggest strategies
in polypeptides. Redox-based regulation by NO revers- to clarify important questions on the mechanism of ac-
ibly targets metal-coordinating centers (direct reaction) tion of NO:
and thiol-containing proteins (by S-nitrosylation) with How Is Regulated Exocytosis Specifically Controlled
signature allosteric requirements (Stamler et al., 2001). by the General Transport Factor NSF? The identification
The inherently versatile nature of NO chemistry/biology of NSF, which is required for all membrane trafficking
may thus integrate and coordinate distinct individual processes in the cell, as a primary NO target suggests
that NO may also affect basal intracellular membranereactions into a physiological response, such as the
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Figure 1. Conservation of Functionally Criti-
cal Cysteines Targeted by Nitrosylation within
NSF
The basic domain organization of NSF is out-
lined and the positions corresponding to
functionally critical S-nitrosylation sites (C91
and C264) are boxed. The amino acid number-
ing is based on the rat NSF sequence. Cyste-
ines are highlighted in red and conserved
threonines in the D2 domain are highlighted
in blue. Vertebrate sequences are shaded in
light blue. Please note that in insects the cys-
teines conferring to the C91 site are variable
in number and position (shaded in gray). Re-
markably, Drosophila expresses two NSF iso-
forms (one lacking cysteines) in a temporally
and spatially distinct pattern (Pallanck et al.,
1995). Sequence alignments are based on
BLAST searches.
trafficking. Lowenstein and colleagues report neither a reveal potential reaction mechanisms. Interestingly,
NSF sequence comparisons reveal that the functionallyreduction of cell viability nor an inhibition of constitutive
exocytosis, which indicates that under the employed critical cysteines targeted by nitrosylation are not strictly
conserved (Figure 1). In site 1 (corresponding to aminoexperimental conditions, general membrane trafficking
is not significantly affected. It is possible that regulated acid 91 in rat NSF) a cysteine is found in vertebrates
and most insects, but not in fungi and plants. Site 2exocytosis may have a particularly high demand for NSF
and a partial reduction of NSF’s catalytic activity by (residue 264), which is localized to the Walker box, is
highly conserved and only 2 amino acids are allowed inS-nitrosylation (which needs to be tested in quantitative
biochemical assays) could thus be selective. Interest- this position—either a cysteine or a threonine. A cysteine
is found solely in vertebrates and seems to be a recentingly, reduced levels of NSF expression are observed in
schizophrenic patients, providing independent evidence evolutionary adaptation. This observation provides a
unique opportunity to study the selective function offor a potential regulatory role of NSF and suggesting
that S-nitrosylation of NSF may also play a role in neuro- S-nitrosylation of NSF in complex physiological environ-
ments. For example, NSF gene replacement experi-transmission (Mirnics et al., 2000). An alternate view is
that NSF inactivation occurs locally, being confined to ments in vertebrates (e.g., C264T mutation) should not
interfere with the general NSF function, but selectivelyNO microdomains at the plasma membrane. Constitu-
tive eNOS is normally targeted to cholesterol-enriched eliminate any NSF-specific regulation by NO. Such
transgenic animals would be useful to determine thecaveolae at the plasma membrane by myristoylation,
although it may translocate to the cytosol upon stimula- ultimate role of NSF S-nitrosylation in a broad variety
of physiological processes.tion. Since NO and O2 (the two substrates required for
S-nitrosylation) partition rapidly into lipid bilayers, S-nitro-
sylation close to membranes is favorable (Liu et al., Thomas H. So¨llner and Sonia Sequeira
1998). Yet another possibility is that SNAREs are not Memorial Sloan-Kettering Cancer Center
the primary targets for NO-mediated NSF inactivation. Cellular Biochemistry & Biophysics Program
Indeed, other substrates such as the AMPA receptor- New York, New York 10021
PICK 1 complexes have been identified (Hanley et al.,
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Pallanck, L., Ordway, R.W., Ramaswami, M., Chi, W.Y., Krishnan, on an intact response to TSH. Thus, TSHR null mice
K.S., and Ganetzky, B. (1995). J. Biol. Chem. 270, 18742–18744. have severe osteoporosis. Heterozygous TSHR/ mice
So¨llner, T.H. (2003). Mol. Membr. Biol. 20, 209–220. are euthyroid, with normal levels of T3, T4, and TSH,
Stamler, J.S., Lamas, S., and Fang, F.C. (2001). Cell 106, 675–683. but nevertheless have a significant decrease in bone
Turner, K.M., Burgoyne, R.D., and Morgan, A. (1999). Trends Neu- density. Additionally, supplementation of TSHR/ mice
rosci. 22, 459–464. with thyroid hormone normalizes body weight, but not
bone mass. Interestingly, focal osteosclerosis accom-
panies global osteoporosis in TSHR/ mice. These ar-
eas of dense bone have histological features indicating
rapid formation. Thus, TSH appears to affect both osteo-
blasts and osteoclasts.TSH, The Bone Suppressing
Because a role for TSH in bone remodeling was notHormone
predicted, expression of TSHRs in bone cells had not
previously been examined. The present authors, how-
ever, convincingly demonstrate expression of TSHRs on
the surface of both osteoblast and osteoclast precur-The skeleton is a dynamic organ whose structural in-
sors, in vivo and in vitro. They document suppressivetegrity depends on constant remodeling, controlled by
effects of TSH on osteoclast and osteoblast differentia-many local and systemic factors. In this issue of Cell,
tion, and enhanced maturation of cells lacking TSHR.Abe et al. (2003) identify thyroid-stimulating hormone
Therefore, unlike thyroid hormone, which acts directly(TSH) as an important regulator of this process.
only on osteoblasts, TSH suppresses the function of
both osteoblasts and osteoclasts in a cell autonomousThyroid disease and osteoporosis are prevalent in the
fashion. In mice unable to respond to TSH due to ab-elderly, and von Recklinghausen recognized over 100
sence of the receptor, the result is a high turnover stateyears ago that hyperthyroidism can cause osteoporosis.
in which bone resorption outpaces bone formation (Fig-Increased circulating thyroid hormone induces a high
ure 1).turnover state in bone, with increased activity by osteo-
Osteoblast differentiation requires expression of theblasts and osteoclasts. The resorptive activity of osteo-
transcription factors Runx-2 and osterix, but is also influ-clasts, however, predominates, eventuating in decreased
enced by the Wnt pathway (especially via the coreceptorstructural integrity of the skeleton (Greenspan and
LRP-5) and activation of Flk-1, a VEGF receptor (Karse-Greenspan, 1999). Thus far, investigators have focused
nty and Wagner, 2002). TSH suppresses expression ofon the direct effects of active thyroid hormone (triiodo-
LRP-5 and Flk-1, but does not affect Runx-2 or osterix.thyronine, T3) on bone cells, via thyroid hormone recep-
Osteoblasts influence osteoclast differentiation in vivotors (TR1 and TR), members of the nuclear hormone
via their expression of RANKL and M-CSF (Teitelbaumreceptor family that induce transcription in a ligand-
and Ross, 2003). The enhanced osteoclastogenesis ofdependent manner (Britto et al., 1994). Osteoblasts ex-
TSHR/ mice cannot be attributed to enhanced expres-
press TRs and respond to T3 with increased proliferation
sion of either M-CSF or RANKL, indicating that this is
and expression of lineage-specific markers such as al-
not the point at which osteoclast and osteoblast activity
kaline phosphatase, osteocalcin, and collagen. Interest-
becomes uncoupled. Instead, the mutant animals have
ingly, although osteoclasts have TRs, their response to increased levels of TNF, a cytokine that synergizes
T3 appears to be mediated entirely by osteoblasts. In with RANKL in the osteoclastogenic process.
the presence of vitamin D3, T3 induces osteoblasts to RANKL activates a number of signaling pathways in
express of RANK ligand (RANKL), the key osteoclasto- osteoclasts, including NF-B and the MAPKs (JNK, ERK,
genic cytokine. Additionally, mice lacking the known and p38). Osteoclast precursors lacking one or both
active isoforms of TRs have retarded bone growth and copies of the TSHR gene exhibit increased signaling
maturation, but do not manifest increased bone mineral through JNK and NF-B, but not ERK or p38. Likewise,
density, as would be predicted if, in fact, T3 is an impor- coadministration of TSH with RANKL in wild-type osteo-
tant stimulus of bone resorption in vivo (Gothe et al., clast cultures inhibits NF-B and JNK. Thus, TSH arrests
1999). osteoclast differentiation through defined pathways
A previously unexplored consequence of hyperthy- downstream of RANKL.
roidism is suppression of thyroid stimulating hormone Perhaps the most intriguing issue posed by the dis-
(TSH), which is produced by the anterior pituitary and covery of this new regulator of skeletal remodeling is
directly controls production and release of thyroid hor- the mechanism by which TSH exerts its effects. The
mones by thyroid follicles. The TSH receptor (TSHR) is TSHR is a member of the seven transmembrane G pro-
a seven transmembrane glycosylated G protein-coupled tein-coupled receptor family that also includes the calci-
protein expressed by many tissues beyond the thyroid tonin and parathyroid hormone (PTH) receptors, both
(Davies et al., 2002). Although several extrathyroidal regulators of bone turnover. Although the calcitonin re-
functions for TSH have been proposed, evidence sup- ceptor is expressed on both osteoclasts and osteo-
porting this contention is scant. In this issue of Cell, Abe blasts, its primary function is inhibition of bone resorp-
et al. (2003) demonstrate a critical role for TSH in skeletal tion, decreasing osteoclast motility and secretion, by
remodeling that is independent of its effects on circulat- osteoclasts, of acid and proteases (Samura et al., 2000).
ing thyroid hormone. Using mice in which the TSHR The PTH receptor is highly expressed only on osteo-
gene is replaced by GFP, they find bone mineral density, blasts, which PTH impacts in a biphasic manner (Locklin
et al., 2003). Specifically, intermittent administration ofin face of normal levels of thyroid hormone, depends
